Full Text Available
Note: Clicking the button above will open the full text document at the original institutional repository in a new window.
Angiotensin converting enzyme inhibitors (ACEi) are routinely used as first line treatment for hypertensive patients because of their protective effects against heart and kidney disease. Despite their clinical benefits, ACEi used is associated with adverse side effects such as life threatening angio...
| Main Author: | |
|---|---|
| Other Authors: | |
| Format: | Thesis |
| Language: | English |
| Published: |
Division of Medical Biochemistry
2015
|
| Subjects: | |
| Tags: |
No Tags, Be the first to tag this record!
|
| _version_ | 1867614490959282176 |
|---|---|
| access_status_str | Open Access |
| author | Moholisa, Retsilisitsoe Raymond |
| author2 | Sturrock, Edward D |
| author_browse | Moholisa, Retsilisitsoe Raymond Sturrock, Edward D |
| author_facet | Sturrock, Edward D Moholisa, Retsilisitsoe Raymond |
| author_sort | Moholisa, Retsilisitsoe Raymond |
| collection | Thesis |
| description | Angiotensin converting enzyme inhibitors (ACEi) are routinely used as first line treatment for hypertensive patients because of their protective effects against heart and kidney disease. Despite their clinical benefits, ACEi used is associated with adverse side effects such as life threatening angioedema (ACEi-AE) and persistent dry cough (ACEi-cough) |
| format | Thesis |
| id | oai:open.uct.ac.za:11427/11480 |
| institution | University of Cape Town (South Africa) |
| language | eng |
| last_indexed | 2026-06-10T12:52:52.975Z |
| license_str | Not specified — see source repository |
| provenance_str_mv | Harvested via OAI-PMH from UCTD — University of Cape Town Open Access Repository |
| publishDate | 2015 |
| publishDateRange | 2015 |
| publishDateSort | 2015 |
| publisher | Division of Medical Biochemistry |
| publisherStr | Division of Medical Biochemistry |
| record_format | dspace |
| source_str | UCTD — University of Cape Town Open Access Repository |
| spelling | oai:open.uct.ac.za:11427/11480 Genetic and biochemical analysis of ACE inhibitor-induced angioedema in black and coloured South Africans Moholisa, Retsilisitsoe Raymond Sturrock, Edward D Medicine Angiotensin converting enzyme inhibitors (ACEi) are routinely used as first line treatment for hypertensive patients because of their protective effects against heart and kidney disease. Despite their clinical benefits, ACEi used is associated with adverse side effects such as life threatening angioedema (ACEi-AE) and persistent dry cough (ACEi-cough) 2015-01-05T18:50:02Z 2015-01-05T18:50:02Z 2011 Master Thesis Masters MSc http://hdl.handle.net/11427/11480 eng application/pdf Division of Medical Biochemistry Faculty of Health Sciences University of Cape Town |
| spellingShingle | Medicine Moholisa, Retsilisitsoe Raymond Genetic and biochemical analysis of ACE inhibitor-induced angioedema in black and coloured South Africans |
| thesis_degree_str | Master's |
| title | Genetic and biochemical analysis of ACE inhibitor-induced angioedema in black and coloured South Africans |
| title_full | Genetic and biochemical analysis of ACE inhibitor-induced angioedema in black and coloured South Africans |
| title_fullStr | Genetic and biochemical analysis of ACE inhibitor-induced angioedema in black and coloured South Africans |
| title_full_unstemmed | Genetic and biochemical analysis of ACE inhibitor-induced angioedema in black and coloured South Africans |
| title_short | Genetic and biochemical analysis of ACE inhibitor-induced angioedema in black and coloured South Africans |
| title_sort | genetic and biochemical analysis of ace inhibitor induced angioedema in black and coloured south africans |
| topic | Medicine |
| url | http://hdl.handle.net/11427/11480 |
| work_keys_str_mv | AT moholisaretsilisitsoeraymond geneticandbiochemicalanalysisofaceinhibitorinducedangioedemainblackandcolouredsouthafricans |